MedTrace Logo

Promotion of Wellbeing in Women Athletes

NCT03064230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-02-27

No results posted yet for this study

Summary

The Female Athlete Triad is a medical condition often observed in physically active girls and women, and involves 3 components: (1) low energy availability with or without disordered eating, (2) menstrual dysfunction, and (3) low bone mineral density. An early intervention is essential to prevent its progression to serious endpoints including clinical eating disorders, amenorrhea, and osteoporosis that can affect the quality of life of these patients and even compromise the athletic performance.

All patients, aged between 14 and 40 years, who met the inclusion and exclusion criteria, were prospectively enrolled in this observational study and were divided into two groups: Athletes agonists (Experimental Group or Group A) and women who do not perform agonistic sports (Control Group or Group B). In both groups of patients, the investigators administered two types of questionnaires: a standardized quality of Life questionnaire, validated in Italian (SF-12) and a screening questionnaire recommended by the Female Athlete Triad Expert Panel.

Conditions

  • Quality of Life

Interventions

OTHER

QoL questionnaire SF-12 and and a screening questionnaire

patient were asked to fill questionnaires

Sponsors & Collaborators

  • Federazione medicina sportiva italiana (FMSI)

    collaborator UNKNOWN

  • Campus Bio-Medico University

    lead OTHER

Principal Investigators

  • Roberto Angioli · University Campus Bio Medico of Rome

Eligibility

Min Age
14 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2016-05-30
Completion
2016-05-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03064230 on ClinicalTrials.gov